ShawnKothariMD

PubMed

• 46 citations
  Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
  Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis B. Nabors, Manmeet S Ahluwalia, Roger Stupp, M...> ;Clinical Cancer Research. 2021 Sep 24
• Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy.
  Shawn Kothari, Everett E. Vokes> ;Chinese Clinical Oncology. 2019 Sep 2
• 1088 citations
  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Nature. 2017 May 4
• 366 citations
  Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
  Stephen J Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan W. Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Peter Gabriel, Jeffrey C. Thompson, S...> ;Lung Cancer. 2017 Apr 1
• 22 citations
  Central venous stenosis is more often symptomatic in hemodialysis patients with grafts compared with fistulas.
  Scott O. Trerotola, Shawn Kothari, Therese Sammarco, Jesse Chittams> ;Journal of Vascular and Interventional Radiology. 2014 Mar 1
• Join now to see all